Diabetes Newswire
1 - MannKind to Present at the Fourth Annual JMP Securities Healthcare Focus Conference
VALENCIA, Calif.-(Business Wire)-September 29, 2009 - MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing and commercializing treatments for diabetes and cancer, announced today that it will present at the Fourth Annual JMP Securities Healthcare Focus Conference on Tuesday...
2 - Study Shows AFRESA® Provides Rapid Suppression of Endogenous Glucose Production in Diabetes Patients
VIENNA-(Business Wire)-September 29, 2009 - AFRESA® (insulin human [rDNA origin]) Inhalation Powder is a well-tolerated, ultra rapid acting insulin able to more closely replicate normal glucose suppression than currently available insulins, according to data presented at the 45th Annual Meeting...
3 - Vitae Receives $8 Million Payment from Boehringer Ingelheim for Achievement of 11beta-HSD-1 Program Milestone
FORT WASHINGTON, Pa.-(Business Wire)-September 29, 2009 - Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned an $8 million milestone payment from Boehringer Ingelheim for achievement of a performance milestone in their...
4 - Computable Genomix Announces Contest For Genomics Researchers
MEMPHIS, Tenn.-(Business Wire)-September 29, 2009 - Memphis-based Computable Genomix today announced it will launch a contest on Oct. 1, 2009, to coincide with the release of GeneIndexer, the company’s next-generation Web-based text-mining tool. Publish or Perish will award a $10,000 grant to each...
5 - Research and Markets: "Improved Therapies and Innovative Drug Delivery Techniques Are Anticipated to Revolutionise the Global Diabetes Market by 2015," Notes the Analyst of This Research
DUBLIN-(Business Wire)-September 28, 2009 - Research and Markets has detailed stringent policies for the approval of diabetic drugs. These policies compel lengthier clinical trials, often resulting in the delayed launch of new drugs and increased drug development costs. "The not-so conducive...
6 - Halozyme Begins Clinical Trial to Compare Three Insulin Analogs and Provides Update on Ultrafast Insulin Program
SAN DIEGO-(Business Wire)-September 28, 2009 - Halozyme Therapeutics, Inc. (Nasdaq:HALO) today announced the commencement of a Phase 1 clinical study that will assess the effects of three approved prandial (mealtime) insulin analogs administered with its proprietary rHuPH20 (PH20) hyaluronidase...
7 - Merck Statement About JANUVIA™ (sitagliptin) and JANUMET™ (sitagliptin/metformin)
WHITEHOUSE STATION, N.J.-(Business Wire)-September 25, 2009 - Merck & Co., Inc., issued the following statement today in response to the U.S. Food and Drug Administration's (FDA's) update on JANUVIA (sitagliptin) and JANUMET (sitagliptin/metformin). "Merck has thoroughly reviewed the safety data...
8 - Diabetes Foot Specialists Say Cost-Effective Wound Therapy Underused Due to Healthcare Reimbursement Incentives
-(Business Wire)-September 25, 2009 - WHAT: Every 30 seconds, across the globe an individual loses a limb due to poor diabetes management. In the U.S., diabetes affects nearly 24 million people. When poorly controlled, diabetes results in nerve damage and poor circulation to the legs and feet...
9 - NEVO™ Sirolimus-Eluting Coronary Stent Associated with Significantly Less Chest Pain at Six Months Than Taxus® Liberte® Stent
SAN FRANCISCO-(Business Wire)-September 24, 2009 - At six months, patients receiving the NEVO™ Sirolimus-eluting Coronary Stent reported significantly less chest pain (also known as angina) than those receiving the Taxus® Liberte® Stent. Patients also reported improvements in their overall...
10 - California Physician Organization Top Performers and Most Improved Honored by Integrated Healthcare Association
OAKLAND, Calif.-(Business Wire)-September 24, 2009 - In the midst of a national debate about the future of health care in America, the Integrated Healthcare Association (IHA) today announced the physician organizations that achieved overall performance in the top 20% in 2008 based on the statewide...
11 - Advanced BioHealing Showcases Dermagraft at Georgetown University’s Diabetic Limb Salvage Conference
WASHINGTON-(Business Wire)-September 24, 2009 - Advanced BioHealing, Inc. (ABH), a leader in commercializing the promise of regenerative medicine, today announced that Dermagraft®, its bio-engineered skin substitute that repairs tissue damaged by disease or injury and supports the body’s...
12 - Alkermes Announces Amylin and Lilly Will Present More than 20 Studies for Exenatide at EASD 2009
SAN DIEGO & INDIANAPOLIS & CAMBRIDGE, Mass.-(Business Wire)-September 24, 2009 - Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc. (Nasdaq: ALKS) will unveil data from more than 20 studies at the 45th Annual Meeting of the European...
13 - Clinical Study Supports Accuracy of Store Brand TRUEresult Blood Glucose Monitoring System in Comparison to Name Brand Systems
FORT LAUDERDALE, Fla.-(Business Wire)-September 23, 2009 - Home Diagnostics, Inc. (NASDAQ:HDIX), a leading manufacturer and marketer of diabetes testing supplies, today announced that a new study has shown that its TRUEresult® store brand blood glucose monitoring system is comparable to the...
14 - Blue Cross Blue Shield of Massachusetts Foundation Awards $1.25 Million to 11 Organizations Working to Reduce Health Care Disparities
BOSTON-(Business Wire)-September 23, 2009 - The Blue Cross Blue Shield of Massachusetts Foundation has awarded $1.25 million in grants to 11 community health organizations around the Commonwealth to address health care disparities on the basis of race, ethnicity, immigration status, age, mental...
15 - MSGI Announces First Nanobeak Product -- Handheld Bloodless Diabetes Test
NEW YORK-(Business Wire)-September 23, 2009 - MSGI Security Solutions Inc. (OTCBB: MSGI) today reported that the Company is launching its first product derived from NASA technology, a handheld test for Diabetes, which uses breath instead of blood. Nanobeak Inc., an MSGI subsidiary, is a...
16 - 2.25 MM CYPHER® Sirolimus-eluting Coronary Stent Approved by FDA
BRIDGEWATER, N.J.-(Business Wire)-September 21, 2009 - Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that it has received approval from the U.S. Food and Drug Administration (FDA) for a new, smaller version of the...
17 - Sloning Closes Growth Financing Round Led by LBBW Venture
PUCHHEIM, Germany-(Business Wire)-September 21, 2009 - Sloning BioTechnology GmbH, the worldwide leading supplier of combinatorial gene libraries, received additional investments from all of its institutional shareholders: HBM BioVentures, LBBW Venture, DEWB and KfW to finance the company’s...
18 - SUN CRYSTALS® Shines as New All-Natural Sweetener
FORT WASHINGTON, Pa.-(Business Wire)-September 21, 2009 - Love sugar but looking for a 100 percent natural, low-calorie way to stir up how you sweeten beverages, bake and cook? SUN CRYSTALS® All-Natural Sweetener from McNeil Nutritionals, LLC, is the first sweetener made from two simple ingredients...
19 - Covidien to Be Presenting Sponsor for American Diabetes Association EXPOs in New York and Minneapolis
NORTH HAVEN, Conn.-(Business Wire)-September 21, 2009 - Covidien (NYSE: COV), a leading global provider of health care products, today announced it will be the presenting sponsor of the American Diabetes Association’s Diabetes EXPOs in New York City and Minneapolis. In addition, Covidien is...
20 - Incyte Announces Positive Top-Line Phase IIb Results for Topical INCB18424 in Psoriasis
WILMINGTON, Del.-(Business Wire)-September 21, 2009 - Incyte Corporation (Nasdaq:INCY) announced positive clinical trial results for a topical formulation of its lead janus kinase (JAK) inhibitor, INCB18424, in psoriasis. These results were obtained from a multi-center three-month Phase IIb trial...
21 - PerkinElmer Launches Columbus™ 2.0 High Content Screening Platform for High-Volume Image Data Management and Analysis
BOSTON-(Business Wire)-September 21, 2009 - At the High Content Analysis East conference in Boston, PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the launch of the Columbus™ 2.0 platform, its flagship high content...
22 - KCI Sponsors Georgetown Diabetic Limb Salvage Conference Symposium Featuring Top Limb Preservation Experts
SAN ANTONIO-(Business Wire)-September 18, 2009 - Kinetic Concepts, Inc. (KCI) will sponsor a CME-accredited panel discussion, “The Role of NPWT in the Team Approach to Limb Salvage: Case Studies,” at the 3rd Annual Georgetown Diabetic Limb Salvage conference September 24-26. At the symposium...
23 - Integrative Therapeutics, Inc. Seeking 2010 Residency Sites for STAIR Scholarship Program
GREEN BAY, Wis.-(Business Wire)-September 18, 2009 - Integrative Therapeutics, Inc (ITI®), in collaboration with the American Association of Naturopathic Physicians (AANP), is seeking qualified residency sites for the fourth year of the ITI & AANP STAIRSM Residency Scholarship Program. This...
24 - New Program Offers Community Pharmacies an Expanded Role in Diabetes Self-Management Training, Increases Access and Treatment Options for Patients
ALEXANDRIA, Va.-(Business Wire)-September 17, 2009 - The National Community Pharmacists Association (NCPA) and the American Association of Diabetes Educators (AADE) today announced a partnership that will expand counseling options for patients while offering community pharmacies a path to be...
25 - Hythiam Raises Approximately $7 Million in Registered Direct Offering
LOS ANGELES-(Business Wire)-September 17, 2009 - Hythiam, Inc. (NASDAQ:HYTM) announced today that it has entered into definitive agreements to sell 9,333,334 shares of its common stock at a price per share of $.75 to institutional investors pursuant to a registered direct offering, representing...
26 - NXT Nutritionals is Shipping SUSTA™ Natural Sweetener to Shaw’s, the Second-Largest Supermarket Chain in New England
HOLYOKE, Mass.-(Business Wire)-September 17, 2009 - NXT Nutritionals Holdings, Inc., (OTCBB: NXTH) announced it is shipping SUSTA™ Natural Sweetener, the great tasting, all-natural, healthier sweetener, in 50 Packet Boxes to New England’s second largest supermarket chain, Shaw’s...
27 - New Essentials Glycemic Health Brand Pasta Launched Using Hi-maize Natural Resistant Starch
BRIDGEWATER, N.J.-(Business Wire)-September 17, 2009 - National Starch Food Innovation today announced the launch of a new Hi-maize-enriched pasta by Racconto, a leading U.S. importer-producer of private label and branded Italian pasta. The all-natural Essentials Glycemic Health pasta line from...
28 - Bioheart Inc. Announces Positive Results in the MARVEL Phase II/III Clinical Trial
SUNRISE, Fla.-(Business Wire)-September 16, 2009 - Bioheart, Inc. (OTCBB:BHRT), presented positive efficacy data from part 1 of its Phase II/III clinical trial at the Heart Failure Society of America (HFSA) Meeting in Boston, Massachusetts. Thomas Povsic, MD, Ph.D., Assistant Professor of Medicine...
29 - CHI Launches Podcast Highlighting Disparities in Diabetes Care for Minorities
LA JOLLA, Calif.-(Business Wire)-September 16, 2009 - California Healthcare Institute: WHO: Gary Puckrein, Ph.D., president and chief executive officer, National Minority Quality Forum Kirk Geter, D.P.M., chief of podiatry, Howard University Hospital David Gollaher, Ph.D., president...
30 - Alliance Health Networks Closes $3.3 Million Financing Led by Highway 12 Ventures
SALT LAKE CITY-(Business Wire)-September 16, 2009 - Alliance Health Networks, Inc. today announced that it has closed a $3.3 million Series C Preferred Stock financing led by Highway 12 Ventures. EPIC Ventures, Series B lead investor, also participated in the Series C round along with other...
31 - AVANIR to Present at the UBS Global Life Sciences Conference
ALISO VIEJO, Calif.-(Business Wire)-September 16, 2009 - AVANIR Pharmaceuticals, Inc. (NASDAQ:AVNR) today announced that the Company will present at the UBS Global Life Sciences Conference on Wednesday, September 23rd at 4:00 p.m. Eastern time (1:00 p.m. Pacific time) at the Grand Hyatt New York...
32 - PerkinElmer Purchases GE Healthcare’s Catalog Radiochemicals, SPA Reagents and Cytostar-T Plate Assets
WALTHAM, Mass.-(Business Wire)-September 16, 2009 - PerkinElmer, Inc., a global leader focused on improving the health and safety of people and their environment, today announced that it has purchased the assets of GE Healthcare’s 3H and 14C Catalog Radiochemicals, Scintillation Proximity Assay...
33 - Home Diagnostics, Inc. Wins Governor’s Export Excellence Award
FORT LAUDERDALE, Fla.-(Business Wire)-September 15, 2009 - Home Diagnostics, Inc. (NASDAQ:HDIX), a leading developer, manufacturer, and marketer of blood glucose monitoring systems, today announced that the company has received a 2009 Governor’s Export Excellence Award. The award, part of the 2009...
34 - PPD Opens Global Central Lab in Singapore
WILMINGTON, N.C.-(Business Wire)-September 15, 2009 - PPD, Inc. (Nasdaq: PPDI) today announced it has opened its global central lab facility in Singapore, strengthening its ability to provide biopharmaceutical clients an extensive range of customized laboratory services in Southeast Asia, a...
35 - Medifacts Presents Free Symposium on “Meeting the Evolving Cardiac Safety Requirements from Diabetes to Oncology” at the North Carolina Biotech Center
-(Business Wire)-September 15, 2009 - Medifacts International: Who: Medifacts International, Jeff Heilbraun and Boaz Mendzelevski, MD Title: Recognizing the Cardiac Safety Continuum; Meeting the Evolving Cardiac Safety Requirements for New Medicinal Entities from Diabetes to Oncology...
36 - THE SAGE GROUP Supports the “Stop P.A.D.” Petition Drive to Expand Medicare Coverage to Test Patients for Peripheral Arterial Disease
ATLANTA-(Business Wire)-September 15, 2009 - In recognition of National P.A.D. Awareness Month, Mary L. Yost, President of THE SAGE GROUP recommends that patients, relatives, and the medical community join the campaign to increase access to a simple noninvasive test to diagnose peripheral arterial...
37 - AmMed Direct® Named Nashville’s Fastest-Growing Company
NASHVILLE, Tenn.-(Business Wire)-September 14, 2009 - AmMed Direct, a Nashville-based provider of diabetes testing supplies, prescription medications and support services for people with diabetes, has been named the fastest-growing private company in the Middle Tennessee area by the Nashville...
38 - Biodel Inc. to Present at Morgan Stanley 2009 Global Healthcare Unplugged Conference on September 14th, 2009
DANBURY, Conn.-(Business Wire)-September 11, 2009 - Biodel Inc. (Nasdaq: BIOD) today announced that Dr. Solomon Steiner, Chairman and CEO of Biodel, will present a corporate update at the Morgan Stanley 2009 Global Healthcare Unplugged Conference in New York on Monday, September 14, 2009 at 4:30...
39 - VitalWear Launches Ad Campaign Based on Center for Disease Control Findings
SOUTH SAN FRANCISCO, Calif.-(Business Wire)-September 11, 2009 - VitalWear, Inc. (www.vitalwear.com), a leader in thermal compression medical devices announced that it is launching a Direct Mail and Web campaign in an effort to educate customers on a recent report from the Center for Disease Control...
40 - Research and Markets: Australia Diabetes Care Devices Market Analysis and Forecasts Through to 2015
DUBLIN-(Business Wire)-September 11, 2009 - Research and Markets , partnerships, venture capital and private equity investments. Qualitative analysis of market drivers, market limiters regulatory issues and future outlook. Reasons to buy: Understand what the new growth opportunities are within the...
41 - Research and Markets: Brazil Diabetes Care Devices Market Analysis and Forecasts to 2015 Reviews the Competitive Landscape In Terms Of Mergers and Acquisitions, Pipeline Products and Technology Offerings
DUBLIN-(Business Wire)-September 10, 2009 - Research and Markets , partnerships, venture capital and private equity investments. Qualitative analysis of market drivers, market limiters regulatory issues and future outlook. Reasons to buy Understand what the new growth opportunities are within the...
42 - Research and Markets: Diabetic Neuropathy Therapy Area Pipeline Report - A Comprehensive Insight into the Pipeline Status of Diabetic Neuropathy Drugs
DUBLIN-(Business Wire)-September 10, 2009 - Research and Markets has announced the addition of the "Diabetic Neuropathy Therapy Area Pipeline Report" report to their offering. Life Science Analytics, Diabetic Neuropathy Therapy Area Pipeline Report contains detailed information on the diabetic...
43 - 1,500 Clinicians, 55 World-Renowned Clinical Experts, and 21 Medical Societies Convene in Boston for the 4th Annual Cardiometabolic Health Congress
BOSTON-(Business Wire)-September 10, 2009 - The 2009 Cardiometabolic Health Congress (CMHC) will hold its fourth annual meeting October 7–10, 2009, at the Sheraton Boston Hotel. “The current national debate on health care reform and health care cost has begun to focus attention on the issue...
44 - Reportlinker Adds China Medical Equipment Market Analysis and Forecasts to 2015
NEW YORK-(Business Wire)-September 10, 2009 - Reportlinker.com announces that a new market research report is available in its catalogue. Reportlinker Adds China Medical Equipment Market Analysis and Forecasts to 2015...
45 - The Center for Wound Healing to Restate Certain 2008 and 2009 Financial Results
TARRYTOWN, N.Y.-(Business Wire)-September 10, 2009 - The Center for Wound Healing, Inc. (OTCBB:CFWH), a leading operator of comprehensive wound care treatment centers that offer hyperbaric oxygen therapy as well as other advanced wound care treatment modalities, today announced that the...
46 - Research and Markets: Spain Diabetes Care Devices Market Analysis and Forecasts Through to 2015
DUBLIN-(Business Wire)-September 10, 2009 - Research and Markets , partnerships, venture capital and private equity investments. Qualitative analysis of market drivers, market limiters regulatory issues and future outlook. Reasons to buy: Understand what the new growth opportunities are within the...
47 - NXT Nutritionals Launches SUSTA™ Natural Sweetener, Through White Rose Food, Which Distributes to 1,800 Stores from Maryland to Connecticut
HOLYOKE, Mass.-(Business Wire)-September 9, 2009 - As the first step in its campaign to bring SUSTA™ to major food retailers throughout the United States, NXT Nutritionals Holdings, Inc. (OTCBB:NXTH), developer and marketer of SUSTA™ Natural Sweetener, the great tasting, all-natural, healthier...
48 - Leading U.S. Epilepsy Organizations Unite on H1N1 Virus “Swine Flu” Public Health Recommendations for Children with Epilepsy
WEST HARTFORD, Conn. & CHICAGO & WASHINGTON & MIDDLEBURG, Va. & BOSTON & NEW YORK-(Business Wire)-September 9, 2009 - AES, CURE, Epilepsy Foundation, Epilepsy Therapy Project and FACES today announced their support for increased public awareness of H1N1 Virus (“Swine Flu...
49 - Research and Markets: The Top 20 Non-Invasive Blood Glucose Monitoring Device Companies Worldwide
DUBLIN-(Business Wire)-September 9, 2009 - Research and Markets , a non-invasive blood glucose measurement device utilizing near-infrared spectroscopy. Report data field structure is as follows: Company Name Mailing Address Street Address Telephone Fax Email Website Parent Company Name Year...
50 - OSI Pharmaceuticals to Present at the Morgan Stanley Healthcare Conference on Tuesday, September 15, 2009
MELVILLE, N.Y.-(Business Wire)-September 8, 2009 - OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) announced today that OSI Management will present at the Morgan Stanley Healthcare Conference in New York, NY on Tuesday, September 15, 2009 at 3:20pm (Eastern Time) and will provide an overview on the...
51 - Emisphere Technologies Announces Publication in Clinical Pharmacology and Therapeutics of Encouraging Data from an Independent Clinical Study of an Oral Eligen-GLP-1 Formulation on Glucose Homeostasis
CEDAR KNOLLS, N.J.-(Business Wire)-September 8, 2009 - Emisphere Technologies, Inc. (OTC BB: EMIS) today announced the publication of an article in the September issue of Clinical Pharmacology and Therapeutics, that describes previously reported findings of an independent clinical study designed...
52 - ValenTx Completes $22 Million Series B Preferred Stock Financing
CARPINTERIA, Calif.-(Business Wire)-September 8, 2009 - ValenTx, Inc., announced today the closing of a $22 million Series B Preferred Stock financing. The round was led by SV Life Sciences and joined by Covidien Ventures, as well as all the Company’s existing venture capital investors: Sapient...
53 - Hi-Tech Pharmacal to Release First Quarter Earnings and Hold Conference Call on September 9, 2009
AMITYVILLE, N.Y.-(Business Wire)-September 4, 2009 - Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) announced that the Company will release results for its first quarter of Fiscal Year 2010 ended July 31, 2009, prior to the market opening on Wednesday September 9, 2009 and will hold a conference call to...
54 - New Mintel Survey Shows Americans in Denial about Health
CHICAGO-(Business Wire)-September 3, 2009 - We think we’re healthier than we actually are, suggests a new survey from market research leader Mintel. Surveying Americans about their health, Mintel found people’s perceptions strongly contradict national statistics about obesity, illness and...
55 - Reportlinker Adds Global Diabetes Care Devices Market Analysis and Forecasts to 2015
NEW YORK-(Business Wire)-September 3, 2009 - Reportlinker.com announces that a new market research report is available in its catalogue. Reportlinker Adds Global Diabetes Care Devices Market Analysis and Forecasts to 2015...
56 - New Diabetes Device May Be Next Step in Quest for Artificial Pancreas
MINNEAPOLIS-(Business Wire)-September 2, 2009 - At this year’s annual meeting of the International Society for Pediatric and Adolescent Diabetes (ISPAD) in Ljubljana, Slovenia, Medtronic, Inc. (NYSE: MDT) announced the global launch of a novel technology designed to provide additional protection...
57 - Cortex’s CEO to Present at Rodman & Renshaw’s Eleventh Annual Healthcare Conference on September 10, 2009
IRVINE, Calif.-(Business Wire)-September 2, 2009 - Cortex Pharmaceuticals, Inc. (NYSE Amex: COR) President and CEO, Mark A. Varney, Ph.D., will present at Rodman & Renshaw’s Eleventh Annual Healthcare Conference taking place September 9 - 11, 2009, at the New York Palace Hotel. Dr. Varney will...
58 - Health Care Crisis News with Rosalie Michaels Goes Live Sept. 1, 2009
PHOENIX-(Business Wire)-September 1, 2009 - As Washington prepares to battle for America's health, a former Mrs. Arizona takes a humorous approach to America's greatest problem. "I am watching the news and I see Americans wanting to kill each other at town halls just so they can figure out a way...
59 - Toledo-Based ProMedica Health System Introduces Program Series to Target Obesity
TOLEDO, Ohio-(Business Wire)-September 1, 2009 - Toledo, Ohio-based ProMedica Health System (PHS) will launch the second year of a health and wellness initiative called Fields of Green to address northwest Ohio’s and southeast Michigan’s obesity problem. According to the 2009 Ohio Family...
60 - NCPA Urges Congressional Action This Month to Block Severe Medicaid Cuts to Pharmacies
ALEXANDRIA, Va.-(Business Wire)-September 1, 2009 - The National Community Pharmacists Association (NCPA) is urging Congressional action in the next 30 days to preserve the access Medicaid patients have to approximately 23,000 community pharmacies. When the Medicare Improvements for Patients and...
61 - Redpoint Bio to Present at Rodman & Renshaw Annual Global Investment Conference
EWING, N.J.-(Business Wire)-September 1, 2009 - Redpoint Bio Corporation (OTCBB: RPBC), a company focused on the development of healthier foods and beverages and new approaches to the treatment of diabetes and obesity, today announced that Dr. Ray Salemme, Chief Executive Officer of Redpoint Bio...
62 - Metabasis Therapeutics Announces the Resignation of Mark Erion, Ph.D., Metabasis’ President, CEO & CSO
SAN DIEGO-(Business Wire)-September 1, 2009 - Metabasis Therapeutics, Inc. (Nasdaq:MBRX) announced today that Mark Erion, PhD, the Company’s president, chief executive officer and chief scientific officer as well as a member of its board of directors, has resigned as an officer and director of the...
63 - Reportlinker Adds World AMD and Diabetic Retinopathy Pharmaceutical Market 2009-2024
NEW YORK-(Business Wire)-September 1, 2009 - Reportlinker.com announces that a new market research report is available in its catalogue. Reportlinker Adds World AMD and Diabetic Retinopathy Pharmaceutical Market 2009-2024...
64 - Reportlinker Adds Brazil Diabetes Care Devices Market Analysis and Forecasts to 2015
NEW YORK-(Business Wire)-September 1, 2009 - Reportlinker.com announces that a new market research report is available in its catalogue. Reportlinker Adds Brazil Diabetes Care Devices Market Analysis and Forecasts to 2015...
65 - Bio-Matrix Scientific Group Inc. Chairman Comments on New Opportunities for both the Company and Its Majority Owned Subsidiary Entest BioMedical Inc.
SAN DIEGO-(Business Wire)-September 1, 2009 - Bio-Matrix Scientific Group, Inc. (OTCBB:BMSN) Chairman & CEO David Koos commented on the Company’s new opportunities in stem cell research, cancer treatment and intellectual property. Mr. Koos noted, “In the last 3 months we have made...
66 - Study in Annals of Internal Medicine Finds Mediterranean-Style Diet More Effective than Low-Fat Diet In Reducing Need for Drug Therapy in Patients with Newly Diagnosed Type 2 Diabetes
PHILADELPHIA-(Business Wire)-August 31, 2009 - A study published in Annals of Internal Medicine found that compared with a low-fat diet, a low-carbohydrate Mediterranean-style diet led to more favorable changes in glycemic control and coronary risk factors and delayed the need for...
67 - First Patient Enrolled in CYPRESS, a Dual Antiplatelet Therapy Trial with the CYPHER® Sirolimus-Eluting Coronary Stent
BRIDGEWATER, N.J.-(Business Wire)-August 31, 2009 - Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range...
68 - Geron to Present at Four Investor Conferences
MENLO PARK, Calif.-(Business Wire)-August 31, 2009 - Geron Corporation (Nasdaq:GERN) today announced that the company will present updates of its product development programs at four investor conferences in the month of September. Stephen M. Kelsey, M.D., F.R.C.P., F.R.C.Path., executive vice...
69 - Tethys Bioscience Announces Personnel Additions and Promotions
EMERYVILLE, Calif.-(Business Wire)-August 31, 2009 - Tethys Bioscience, Inc. announced today that former Chief Business Officer Michael Richey has been promoted to President, and that several key executives have joined the company’s management team. In the last twelve months the company has...
70 - Research and Markets: Netherlands Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015
DUBLIN-(Business Wire)-August 27, 2009 - Research and Markets has announced the addition of Global Markets Direct's new report "Netherlands Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015" to their offering. This report is an essential source for in-depth information...
71 - Research and Markets: Belgium Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015
DUBLIN-(Business Wire)-August 27, 2009 - Research and Markets has announced the addition of Global Markets Direct's new report "Belgium Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015" to their offering. This report is an essential source for in-depth information and...
72 - GfK Healthcare’s Roper Diabetes Patient Programme Launches Enhanced Annual Study for Western Europe: Six Focused Research Waves Across Five Countries
LONDON-(Business Wire)-August 26, 2009 - GfK Healthcare’s Roper Global Diabetes Programme, the definitive global perspective on diabetes, announced today the launch of its enhanced 2009/2010 Western Europe Patient Study. Offering a holistic perspective of the diabetes patient across five...
73 - Data from a Clinical Study Evaluating GI Dynamics’ EndoBarrier to be Presented at IFSO
PARIS-(Business Wire)-August 26, 2009 - GI Dynamics, a leader in non-surgical treatments for type 2 diabetes and obesity, today announced that additional results from a previously reported clinical study regarding mechanisms of action will be presented on Saturday, August 29, 2009 by Manoel Galvao...
74 - USANA-Supported Clinical Study Results Published in the Journal Obesity and Weight Management
SALT LAKE CITY-(Business Wire)-August 25, 2009 - USANA Health Sciences, Inc. (NASDAQ: USNA) announced today that results of a large, third-party clinical study involving USANA products, conducted at the University of Colorado Denver (UCD), have been published in the August 2009 edition of the...
75 - Advance Auto Parts Launches 2009 National “Sneaker” Sales Campaign to Support Juvenile Diabetes Research Foundation (JDRF)
ROANOKE, Va.-(Business Wire)-August 25, 2009 - Advance Auto Parts, Inc. (NYSE:AAP), a leading automotive aftermarket retailer of parts, batteries, accessories, and maintenance items, and a national partner of the Juvenile Diabetes Research Foundation (JDRF), is proud to announce the launch of its...
76 - Finalists From Germany, France and Switzerland Nominated for The EUROPEAN BIOTECHNICA AWARD 2009
HANNOVER, Germany-(Business Wire)-August 25, 2009 - The EUROPEAN BIOTECHNICA AWARD jury has selected the three finalists for 2009: The nominees are the biopharmaceutical companies NovImmune, Switzerland, TRION Pharma GmbH, Germany, and VIVALIS, France. The award, with prize money totalling 100,000...
77 - Center for Health Value Innovation Endorses National Diabetes Goal to Ensure Awareness, Improve Management of Type 2 Diabetes
ST. LOUIS-(Business Wire)-August 24, 2009 - The Center for Health Value Innovation (www.vbhealth.org), the nation’s premier information exchange for value-based design, today joined with other non-profits, healthcare provider groups, universities, government officials, and corporations to fully...
78 - Fresenius Medical Care Gives Dialysis Patients Freedom To Travel This Fall and Winter
WALTHAM, Mass.-(Business Wire)-August 24, 2009 - As thousands of people plan getaways for the fall and winter travel seasons, easy access to healthcare is a concern for many travelers with chronic health conditions who require life-sustaining treatments. Twenty-six million Americans suffer from...
79 - Research and Markets: Diabetes Drug Discoveries 2009: What the Future Holds - Understand the Prospects for This US$26.3 Billion Sector
DUBLIN, Ireland-(Business Wire)-February 17, 2009 - Research and Markets inhibitors. GLP-1 agonists, also known as incretin mimetics, stimulate insulin secretions from beta cells in the pancreas in response to food intake, in a glucose dependent manner. DPP-4 inhibitors inhibit the DPP-4 enzyme...
80 - InnovationRx and Advanced BioHealing Partner to Provide Patient Support Program
NEWTON, Mass.-(Business Wire)-February 17, 2009 - InnovationRx, a wholly owned subsidiary of Innovation Group (LSE: TiG), announced today that it has partnered with Advanced BioHealing, Inc. (ABH) to conduct a pilot program providing support for patients receiving Dermagraft® treatment. Dermagraft...
81 - The Center for Wound Healing, Inc. to Host Second Quarter 2009 Financial Results Conference Call Wednesday, February 18, 2009 at 10:00 a.m. Eastern Time
TARRYTOWN, N.Y.-(Business Wire)-February 13, 2009 - The Center for Wound Healing, Inc. (OTCBB:CFWH) (“CFWH”), a leading operator of comprehensive wound care treatment centers that offer hyperbaric oxygen therapy as well as other advanced wound care treatment modalities, today announced that...
82 - Research and Markets: The Essential Source for Information, Analysis and Market Forecasts to 2015 on Pipeline Medical Devices
DUBLIN, Ireland-(Business Wire)-February 13, 2009 - Research and Markets has announced the addition of GlobalData 's new report "Insulin Pumps Pipeline Technology And Market Forecasts To 2015" to their offering. "Pipeline Products and Technology Analysis Report" is an essential source of information...
83 - CLSI Publishes Guideline for Urinalysis
WAYNE, Pa.-(Business Wire)-February 11, 2009 - To help improve the quality and reliability of urinalysis results, Clinical and Laboratory Standards Institute (CLSI) updated the document Urinalysis; Approved Guideline—Third Edition (GP16-A3). Urinalysis is a simple, rapid, and basic part of...
84 - Alkermes’ Corporate Presentation to be Webcast at the 21st Annual Roth OC Growth Stock Conference
CAMBRIDGE, Mass.-(Business Wire)-February 10, 2009 - Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live by Roth Capital on Tuesday, February 17, 2009 at 1:30 p.m. PST (4:30 p.m. EST). The presentation will be webcast from the Ritz-Carlton Laguna Niguel...
85 - OSI Pharmaceuticals Announces Notification of ANDA Filing for Tarceva
MELVILLE, N.Y.-(Business Wire)-February 10, 2009 - OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) announced today receipt of a Paragraph IV Certification Notice Letter advising that Teva Pharmaceuticals USA, Inc. submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration...
86 - Research and Markets: In Saudi Arabia, the Prevalence of Type 2 Diabetes is Expected to Rise to between 40-50% by 2020 Says Latest Research Report
DUBLIN, Ireland-(Business Wire)-February 9, 2009 - Research and Markets has announced the addition of the "Stakeholder Opinions: Type 2 Diabetes in the UAE & Saudi Arabia - Growth Opportunities in Fragmented Markets" report to their offering. Introduction This report focuses on the challenges of...
87 - Health Management Associates, Inc. Announces Fourth Quarter and Year-End 2008 Earnings Conference Call and Webcast
NAPLES, Fla.-(Business Wire)-February 6, 2009 - Health Management Associates, Inc. (NYSE:HMA) announced today that on February 23, 2009 it will report results for its fourth quarter and year ended December 31, 2008. HMA will issue a press release after the market closes on Monday, February 23, 2009...
88 - Alkermes Announces Third Quarter Fiscal 2009 Results
CAMBRIDGE, Mass.-(Business Wire)-February 5, 2009 - Alkermes, Inc. (NASDAQ: ALKS) today announced financial results for its third quarter of fiscal 2009. Financial highlights for the quarter ended December 31, 2008, include: Profitable quarter on a GAAP basis, with net income of $112.3 million...
89 - Kaiser Permanente Adopts U.S. Diabetes Conversation Map® Tools as New Standard for Patient Education
ROCKVILLE, Md.-(Business Wire)-February 5, 2009 - Kaiser Permanente’s Mid-Atlantic States Region today announced their decision to enhance their existing diabetes education curriculum with Healthy Interactions U.S. Diabetes Conversation Map® tools, proclaiming them to be more effective in helping...
90 - Research and Markets: Drug Delivery Technology: Revolutionizing Diabetes Treatment - the Recent Approval of Inhalable Insulin is the First Step to Opening New Opportunities
DUBLIN, Ireland-(Business Wire)-February 5, 2009 - Research and Markets and GLP-1 agonists which are thought to have the same limitation. In addition, PPAR agonists may benefit from the utilization of delivery platforms. Use the incisive analysis, commentary, opinions and forecasts provided in...
91 - Certified Diabetic Services, Inc. Terminates Asset Purchase Agreement
NAPLES, Fla.-(Business Wire)-February 5, 2009 - Certified Diabetic Services, Inc. (Pink Sheets:CDIP) is a national direct-to-consumer mail-order distributor of diabetic supplies and pharmaceutical services. On February 3, 2009, the Company terminated the Asset Purchase Agreement and Plan of...
92 - MEDNAX Earns 81 Cents, non-GAAP, in 2008 Fourth Quarter
FORT LAUDERDALE, Fla.-(Business Wire)-February 5, 2009 - MEDNAX, Inc. (NYSE:MD), the national medical group providing newborn, maternal-fetal, pediatric subspecialty and anesthesia physician services, today reported earnings per share of 85 cents for the 2008 fourth quarter, or 81 cents on a...
93 - Pharmacy Groups Seek Changes to CMS DMEPOS Surety Bond Rule
ALEXANDRIA, Va.-(Business Wire)-February 4, 2009 - The National Community Pharmacists Association (NCPA), National Association of Chain Drug Stores (NACDS), and Food Marketing Institute (FMI) recently sent a letter to Acting Administrator of the Centers for Medicare & Medicaid Services (CMS...
94 - DexCom Announces Closing of Public Offering of Common Stock
SAN DIEGO-(Business Wire)-February 4, 2009 - DexCom, Inc. (Nasdaq: DXCM) today announced that it has closed its previously announced public offering of 15,844,000 shares of its common stock at a price of $3.00 per share. In addition, Terrance H. Gregg, DexCom’s President and Chief Executive...
95 - Incyte to Report 2008 Financial Results and 2009 Financial Guidance and Provide Update on Drug Discovery & Development Programs on February 18
WILMINGTON, Del.-(Business Wire)-February 4, 2009 - Incyte Corporation (Nasdaq: INCY) announced today that it has scheduled its fourth quarter and year-end 2008 financial results conference call for 8:30 a.m. ET on Wednesday, February 18, 2009. The schedules for the press release and conference call...
96 - MEDNAX, Inc. Acquires Neonatal Practice
FORT LAUDERDALE, Fla.-(Business Wire)-February 4, 2009 - MEDNAX, Inc. (NYSE:MD) today announced that it has completed the acquisition of a neonatal group based in Arlington, Texas. Arlington Neonatal Intensive Care, P.A., is a two-physician practice that staffs the Level III neonatal intensive...
97 - Satellite Healthcare Announces Optimal Start® — An Orientation Program for Patients With End-Stage Kidney Disease
MOUNTAIN VIEW, Calif.-(Business Wire)-February 3, 2009 - Satellite Healthcare, one of the nation’s first providers of non-for-profit kidney dialysis services, announced today that Optimal Start®—a 90-day orientation program for patients newly diagnosed with end stage renal disease (ESRD)– has...
98 - Affymax to Present at BIO CEO and Investor Conference
PALO ALTO, Calif.-(Business Wire)-February 3, 2009 - Affymax, Inc. (Nasdaq:AFFY) today announced that Arlene Morris, president and chief executive officer, will present at the 11th Annual BIO CEO & Investor Conference on Tuesday, February 10, 2009, at 2:15 p.m. ET at the Waldorf Astoria in New...
99 - Health Benefits of Resveratrol Featured on The CBS News Show 60 Minutes
BOCA RATON, Fla.-(Business Wire)-February 2, 2009 - Researchers proclaimed Resveratrol as the key to the fountain of youth on the CBS News show 60 Minutes this past Sunday. This remarkable key ingredient found in red wine may not only protect your heart - it may very well protect against some of the...
100 - DPS Health Announces New Clients for Internet-Based Weight Management Program
LOS ANGELES-(Business Wire)-February 2, 2009 - DPS Health announces that five healthcare provider organizations will roll out Virtual Lifestyle Management™ (VLM), a clinically-linked, internet-based service that helps overweight adults become active, eat better, lose weight and lead healthier...
101 - The Center for Wound Healing, Inc. Announces Opening of New Center at Jameson Hospital’s South Campus
TARRYTOWN, N.Y.-(Business Wire)-February 2, 2009 - The Center for Wound Healing, Inc. (OTCBB:CFWH)(“CFWH”), a leading operator of comprehensive wound care treatment centers that offer hyperbaric oxygen therapy as well as other advanced wound care treatment modalities, today announced the opening...
102 - Biodel to Report First Quarter Fiscal Year 2009 Results and Top Line Results of Bioequivalence Study on February 5, 2009
DANBURY, Conn.-(Business Wire)-January 30, 2009 - Biodel Inc. (Nasdaq: BIOD) will issue its fiscal first quarter 2009 financial results on February 5, 2009. The company will also discuss the top line results of its study testing the bioequivalence of the 25 IU two part formulation and 100 IU one...
103 - ZOLL Announces Filing of Patent Infringement Suit Against Alsius Corporation and Alsius Medical Corporation
CHELMSFORD, Mass.-(Business Wire)-January 30, 2009 - ZOLL Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of resuscitation devices and related software solutions, announced today that it had filed a lawsuit against Alsius Corporation (Nasdaq: ALUS) and Alsius Medical Corporation in the Central...
104 - CLSI Publishes Approved Guideline for Continuous Interstitial Glucose Monitoring
WAYNE, Pa.-(Business Wire)-January 29, 2009 - Clinical and Laboratory Standards Institute (CLSI) recently published Performance Metrics for Continuous Interstitial Glucose Monitoring; Approved Guideline (POCT05-A), which provides recommendations for methods for determining analytical and clinical...
105 - Aetna Awarded $725,000 to Georgia Non-Profits
ALPHARETTA, Ga.-(Business Wire)-January 29, 2009 - Aetna (NYSE: AET) and the Aetna Foundation in 2008 awarded community grants and sponsorships in Georgia totaling $725,000, with a particular focus on targeting diabetes and related conditions. Among the community grants awarded were: $100,000 to the...
106 - Argenta Discovery and Zafgen Announce Contract Drug Discovery Collaboration in Obesity
HARLOW, United Kingdom & CAMBRIDGE, Mass.-(Business Wire)-January 29, 2009 - Argenta Discovery Ltd., the contract research and Respiratory R & D company, and Zafgen, Inc., a private venture-backed biopharmaceutical company focused on developing novel obesity therapeutics, today announced...
107 - Vitro Receives Notice of Allowance for Adult Stem Cell Patent from the United States Patent and Trademark Office
GOLDEN, Colo.-(Business Wire)-January 28, 2009 - Vitro Diagnostics, Inc. (OTCBB: VODG), dba Vitro Biopharma, announced notification from the United States Patent Office (USPTO) indicating the successful examination of its patent application entitled, “Generation and Differentiation of Adult Stem...
108 - Research and Markets: Global Strategic Business Report Examines the Fundamentals of Hemoglobin A1c Monitoring in Terms of US$ Million
DUBLIN, Ireland-(Business Wire)-January 28, 2009 - Research and Markets For more information visit http://www.researchandmarkets.com/research/e04043/hemoglobin_a1c_mon
109 - Dialysis Patients Urged to Brace for Winter Storms Across U.S.
WALTHAM, Mass.-(Business Wire)-January 27, 2009 - As snow and ice storms blanket much of the country, Fresenius Medical Care North America, operator of the nation’s leading network of dialysis facilities, encourages all dialysis patients in the affected areas to be prepared for bad weather. Winter...
110 - Research and Markets: Practical Lipid Management: Concepts and Controversies
DUBLIN, Ireland-(Business Wire)-January 27, 2009 - Research and Markets has announced the addition of John Wiley and Sons Ltd's new report "Practical Lipid Management: Concepts and Controversies" to their offering. Practical Lipid Management: Concepts and Controversies presents a user-friendly...
111 - Soon-Shiong Joins Board of ITA Partners, a Leading Medical Decision-Support Company
PHILADELPHIA-(Business Wire)-January 26, 2009 - ITA Partners, Inc. is pleased to announce that Patrick Soon-Shiong, MD, noted research scientist and visionary in medical information technology, has joined ITA's Board of Directors. Currently specializing in oncology and end-stage renal disease, ITA...
112 - University of California San Diego Researchers Present Preclinical Data Demonstrating Benefits of TRIOLEX (HE3286) in Model of Obesity Induced Metabolic Disorders
SAN DIEGO-(Business Wire)-January 26, 2009 - Hollis-Eden Pharmaceuticals, Inc. (NASDAQ:HEPH) today announced that researchers from the Department of Medicine, University of California San Diego (UCSD), presented preclinical data demonstrating that the Company’s oral drug candidate TRIOLEX...
113 - DiaKine Therapeutics Drug Improves Type 2 Insulin Action; Reduces Harm of Fat in Preclinical Study
BANFF, Alberta-(Business Wire)-January 22, 2009 - Results of a preclinical study involving DiaKine Therapeutics’ lead drug candidate Lisofylline (LSF) indicate the compound may reduce two key risk factors for type 2 diabetes. LSF was shown to increase insulin action and reduce the level of...
114 - Research and Markets: Educational Review Manual for Endocrinology, Diabetes, and Metabolism with More Unique Focus on Diabetes
Dublin, IRELAND-(Business Wire)-January 22, 2009 - Research and Markets , Eisai, McNeil Consumer Healthcare, Merck & Co., Ortho McNeil Neurologics, Ortho Women’s Health & Urology, Shire, Takeda and Wyeth. Each ERM consists of between 480 and 980 pages of text, with color and...
115 - Akesis Pharmaceuticals Discontinues Sole Clinical Development Program and Announces Intent to File for Chapter 7 Bankruptcy
SAN DIEGO-(Business Wire)-January 21, 2009 - Akesis Pharmaceuticals, Inc. (OTCBB:AKES) today announced it has discontinued its sole clinical development program for AKP-020, a Phase IIa drug candidate for the treatment of diabetes mellitus. “After analyzing the data from our three-month...
116 - Symposium on Advanced Wound Care and Wound Healing Society Spring Meeting (SAWC/WHS Spring) Launches New Limb Preservation Track
DALLAS-(Business Wire)-January 21, 2009 - The Symposium on Advanced Wound Care and Wound Healing Society Spring Meeting (SAWC/WHS Spring), the largest gathering of multidisciplinary wound care specialists in the U.S., will launch its 22nd annual meeting at the Gaylord Texan Hotel and Convention...
117 - Heartbeat CEO to Discuss Agency-Client Models at 8th Annual ePharma Summit
NEW YORK-(Business Wire)-January 21, 2009 - Bill Drummy, founder and CEO of Heartbeat Digital and one of the country’s leading authorities on digital strategy, will join a panel of pharma marketing executives to discuss the complex dynamics of the agency-client relationship as part of the 2009...
118 - ForeverGreen Reports the Launch of a New Heart Health Product Featuring l-Arginine and Based upon Nobel Prize-Winning Research
OREM, Utah-(Business Wire)-January 21, 2009 - ForeverGreen Corp. (OTCBB: FVRG), a manufacturer and distributor of all natural whole foods, today announced the launch of a new Heart Health product, under the Brain Garden label, in accordance with the company’s new focus and branding strategy. Brain...
119 - PerkinElmer ViaCord Research Institute™ to Support Diabetes Research Efforts at University of Massachusetts Medical School
WALTHAM, Mass.-(Business Wire)-January 21, 2009 - PerkinElmer, Inc., a global leader focused on the health and safety of people and their environment, today announced that its ViaCord Research Institute™ (VRI™), which focuses on supporting science, technology and medical treatments using cord...
120 - Opexa Provides Update on Various Corporate Developments
THE WOODLANDS, Texas-(Business Wire)-January 20, 2009 - Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company dedicated to the development of patient-specific cellular therapies for the treatment of autoimmune diseases such as multiple sclerosis (MS) and diabetes, today announced an update on...
121 - Research and Markets: Want Insider Investment Opportunities News on Asia Pacific Diabetes Care Devices? New Report Issues Analysis and Forecasts to 2012
DUBLIN, Ireland-(Business Wire)-January 19, 2009 - Research and Markets has announced the addition of Global Markets Direct's new report "Asia Pacific Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2012" to their offering. Asia Pacific Diabetes Care Devices Investment...
122 - Research and Markets: Educational Review Manual in Endocrinology, Diabetes, and Metabolism is an Influencing Review of the Subject by Leading Practitioners in the Field
DUBLIN, Ireland-(Business Wire)-January 16, 2009 - Research and Markets , Eisai, McNeil Consumer Healthcare, Merck & Co., Ortho McNeil Neurologics, Ortho Women's Health & Urology, Shire, Takeda and Wyeth. Each ERM consists of between 480 and 980 pages of text, with color and...
123 - PerkinElmer ViaCord Research Institute™ and M. D. Anderson Cancer Center Extend Collaboration to Study Cord Blood Stem Expansion System in Adult Transplantation
WALTHAM, Mass.-(Business Wire)-January 16, 2009 - PerkinElmer, Inc., a global leader focused on the health and safety of people and their environment, today announced the extension of a research collaboration between its ViaCord Research Institute™ (VRI™) and The University of Texas M.D...
124 - Research and Markets: Eli Lilly and Company - Company Profile is Supplemented with Graphs and Tabular Information on Key Industry Players
DUBLIN, Ireland-(Business Wire)-January 16, 2009 - Research and Markets 8. Recent News 9. Analyst View List of Tables List of Charts For more information visit http://www.researchandmarkets.com/research/d8963a/eli_lilly_and_comp
125 - Research and Markets: Examine New North American Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2012 Report
DUBLIN, Ireland-(Business Wire)-January 15, 2009 - Research and Markets Inc. Company Profile Metrika, Inc. Company Profile Nipro Diabetes Systems,Inc. Company Profile Pelikan Technologies, Inc. Company Profile Sensys Medical, Inc. Company Profile Xhale Diagnostics, Inc. Company Profile Xilas...
126 - Finalists Announced in American Diabetes Wholesale's 2008 Diabetes Educator of the Year Contest
POMPANO BEACH, Fla.-(Business Wire)-January 15, 2009 - American Diabetes Wholesale's esteemed panel of judges have sorted through hundreds of nominations for the 2008 Diabetes Educator of the Year Contest and are happy to announce the five finalists: Linda C. Aman, RN, BS, MSN, NP-C; Suzanne Swann...
127 - DSS, Inc. Invited to Speak at Sales Conference
JUNO BEACH, Fla.-(Business Wire)-January 14, 2009 - DSS, Inc. today announced that Jay Flejter, Vice President of Research and Development and Jeff Clarke, Consulting Engineer, were invited to speak at the Embarcadero Technologies Sales Kickoff meeting in San Francisco on January 12. According to...
128 - ForeverGreen Reports the Launch of a New Zeolite Product
OREM, Utah-(Business Wire)-January 14, 2009 - ForeverGreen Corp. (OTCBB: FVRG), a manufacturer and distributor of all natural whole foods, today announced the launch of a new product in accordance with the company’s new focus and branding strategy. ForeverGreen has refined and launched a new...
129 - AHRA and Toshiba Announce Patient First Grant Program Winners
TUSTIN, Calif.-(Business Wire)-January 14, 2009 - Helping to fund programs that improve patient care and safety in diagnostic imaging, AHRA: The Association for Medical Imaging Management and Toshiba America Medical Systems, Inc. announced that three leading hospitals were selected as the first...
130 - CIGNA Study: Americans with CDHPs Cut Medical Costs Without Cutting Care
BLOOMFIELD, Conn.-(Business Wire)-January 13, 2009 - CIGNA Choice Fund account-based consumer driven health plans (CDHPs) reduced medical cost trend by 13 percent relative to HMO and PPO plans, even as individuals enrolled in CDHPs use more preventive services and comply with their medical...
131 - DexCom™ Amends Joint Development Agreement with Animas to Bring Continuous Glucose Monitoring-Enabled Insulin Pumps Outside U.S.
SAN DIEGO-(Business Wire)-January 13, 2009 - DexCom, Inc. (NASDAQ:DXCM), a leading provider of continuous glucose monitoring systems for use by people with diabetes at home and by healthcare providers in the hospital, announced today the amendment of its joint development agreement with Animas...
132 - EnteroMedics Announces Eighteen-Month Excess Weight Loss Results from its VBLOC-RF2 Feasibility Study
ST. PAUL, Minn.-(Business Wire)-January 12, 2009 - EnteroMedics Inc., (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, its associated co-morbidities, and other gastrointestinal disorders, today announced interim clinical results from the VBLOC-RF2...
133 - Qnexa Treatment Results in Improved Glucose Control in Obese Non-Diabetic Subjects
MOUNTAIN VIEW, Calif.-(Business Wire)-January 12, 2009 - VIVUS, Inc. (NASDAQ: VVUS), a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today announced additional results from the EQUATE study (OB-301), a phase 3 obesity trial with Qnexa™, an...
134 - GI Dynamics Receives ISO Certification and European CE Mark Approval for the EndoBarrier™ Gastrointestinal Liner System
LEXINGTON, Mass.-(Business Wire)-January 7, 2009 - GI Dynamics, a medical device company pioneering the development of new approaches to treat obesity and metabolic disorders, today announced that it has received ISO 13485:2003 certification for the company’s Lexington facility. The company has...
135 - ForeverGreen Reports Strong Growth Indicators in Japan
OREM, Utah-(Business Wire)-January 6, 2009 - ForeverGreen Corp. (OTCBB: FVRG), a manufacturer and distributor of all natural whole foods, today announced initial results from Japan demonstrate significant potential for the company’s future growth. In November company executives met with...
136 - LabCorp To Present at the Goldman Sachs Healthcare Conference – Reiterates 2008 Guidance and Updates Preliminary 2009 Guidance
BURLINGTON, N.C.-(Business Wire)-January 6, 2009 - Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced that David P. King, Chief Executive Officer, is scheduled to speak at the Goldman Sachs Healthcare Conference in New York City, NY. LabCorp’s presentation is...
137 - VIVUS to Present at the 2009 JP Morgan Healthcare Conference
MOUNTAIN VIEW, Calif.-(Business Wire)-January 6, 2009 - VIVUS, Inc. (NASDAQ: VVUS), a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today announced that Leland F. Wilson, president and CEO, will present an overview of the company at the 27th...
138 - Tranzyme Pharma to Present at the 27th Annual JP Morgan Healthcare Conference
RESEARCH TRIANGLE PARK, N.C.-(Business Wire)-January 6, 2009 - Tranzyme Pharma, a clinical stage biopharmaceutical company engaged in the discovery and development of first-in-class small molecule therapeutics, announced today that Vipin K. Garg, Ph.D., President and CEO, will present at the...
139 - DexCom To Present at the 27th Annual J.P. Morgan Healthcare Conference
SAN DIEGO-(Business Wire)-January 5, 2009 - DexCom, Inc. (NASDAQ:DXCM) today announced that Terrance Gregg, President and Chief Executive Officer, will present an update on DexCom at the 27th Annual J.P. Morgan Healthcare Conference in San Francisco on Thursday, January 15, 2009 at 12:30 p.m. (PST...
140 - Incyte to Present at the 27th Annual JPMorgan Healthcare Conference
WILMINGTON, Del.-(Business Wire)-January 5, 2009 - Incyte Corporation (Nasdaq:INCY) announced today it will present at the 27th Annual JPMorgan Healthcare Conference on Tuesday, January 13, 2009 at 3:30 p.m. (Pacific Time) / 6:30 p.m. (Eastern Time). Paul Friedman, M.D., president and chief...
141 - Home Diagnostics Announces New $5 Million Share Repurchase Program
FORT LAUDERDALE, Fla.-(Business Wire)-January 5, 2009 - Home Diagnostics, Inc. (Nasdaq:HDIX), leading manufacturer and marketer of diabetes testing supplies, today announced that its Board of Directors authorized the company to repurchase up to $5 million of its common stock to be funded with...
142 - Medtech Insight and Windhover Conferences Announce their Upcoming "Investment In Innovation (In3) West” Conference March 2-4, 2009, Las Vegas, NV
IRVINE, Calif.-(Business Wire)-January 5, 2009 - Medtech Insight, a division of Windhover Conferences and a leading provider of business information for the medical device industry, has announced that more than 30 early- to late-stage companies are confirmed to date to present at their upcoming...
143 - Health Dialog Receives Highest Level of NCQA Accreditation for Disease Management
BOSTON-(Business Wire)-January 5, 2009 - Health Dialog Services Corporation today announced that it has again received full patient and practitioner-oriented accreditation from the National Committee for Quality Assurance (NCQA) for disease management services for asthma, coronary heart disease...
144 - ForeverGreen Reports Strong Foundation for Growth into 2009
OREM, Utah-(Business Wire)-December 29, 2008 - ForeverGreen Corp. (OTCBB:FVRG), a manufacturer and distributor of all natural whole foods, today announced steps have been taken to build a strong foundation for growth into 2009. “We have taken great strides in preparing the company for...
145 - Owens & Minor Signs Definitive Agreement to Sell its Direct-to-Consumer, Diabetes Supply Business to Liberty Healthcare Group, Inc.
RICHMOND, Va.-(Business Wire)-December 29, 2008 - Owens & Minor (NYSE: OMI) announced today that it has signed a definitive agreement to sell certain assets of its direct-to-consumer, diabetes supply business to Liberty Healthcare Group, Inc. for $63 million in cash. The assets include patient...
146 - Home Diagnostics to Present at the 27th Annual J.P. Morgan Healthcare Conference
FORT LAUDERDALE, Fla.-(Business Wire)-December 23, 2008 - Home Diagnostics, Inc. (Nasdaq:HDIX), a leading manufacturer and marketer of diabetes testing supplies, announced today that J. Richard Damron, Jr., President and Chief Executive Officer, and Ronald Rubin, Chief Financial Officer, of Home...
147 - Home Diagnostics to Present at the 9th Annual CJS Securities “New Ideas for the New Year” Investor Conference
FORT LAUDERDALE, Fla.-(Business Wire)-December 23, 2008 - Home Diagnostics, Inc. (Nasdaq:HDIX), a leading manufacturer and marketer of diabetes testing supplies, announced today that J. Richard Damron, Jr., President and Chief Executive Officer, and Ronald Rubin, Chief Financial Officer, of Home...
148 - The Center for Wound Healing, Inc. Announces New Lending Agreement with Signature Bank
TARRYTOWN, N.Y.-(Business Wire)-December 23, 2008 - The Center for Wound Healing, Inc. (OTCBB:CFWH) (“CFWH”), a leading manager of comprehensive wound care treatment centers that offer hyperbaric oxygen therapy (“HBOt”) as well as traditional wound care treatment modalities, today...
149 - 2009 Trends and Predictions from the Editors of Consumer Guide to Bariatric Surgery
SAN DIEGO-(Business Wire)-December 23, 2008 - The editors of Consumer Guide to Bariatric Surgery have gazed into their crystal balls to see if the number of bariatric surgeries performed in the United States will continue to increase in 2009. As the obesity epidemic grows, bariatric surgery...
150 - SDI Forecasts Under 5% Growth in New Patient Therapy Starts in the Cholesterol Reducer, Diabetes, and Hypertension Markets in 2009
PLYMOUTH MEETING, Pa.-(Business Wire)-December 18, 2008 - New patient therapy starts in the cholesterol reducer, diabetes, and hypertension markets — three of the largest retail prescription drug categories — will be relatively flat in 2009 compared to previous years, with growth expected to...
Search Our News Using Google Search
Can't find what you want? Try using Google:
